Breaking News Instant updates and real-time market news.

FRTA

Forterra

$8.51

0.11 (1.31%)

18:13
11/04/19
11/04
18:13
11/04/19
18:13

Forterra narrows FY19 net loss view to $35M-$8M from $38M-$16M

Narrows FY19 adjusted EBITDA view to $180M-$200M from $170M-$200M.

  • 05

    Nov

FRTA Forterra
$8.51

0.11 (1.31%)

11/23/18
DBAB
11/23/18
NO CHANGE
Target $5
DBAB
Buy
Forterra price target lowered to $5 from $8 at Deutsche Bank
Deutsche Bank analyst Nishu Sood lowered his price target for Forterra to $5 saying sales growth in the company's Q3 suffered from shipment delays related to poor weather in major markets. However, backlogs were up in the quarter, reflective of the pent up work from project delays and according to management commentary, this should be margin accretive, adds the analyst. He keeps a Hold rating on Forterra shares.
01/23/19
EXAN
01/23/19
UPGRADE
EXAN
Outperform
Forterra upgraded to Outperform from Neutral at Exane BNP Paribas
08/07/19
GSCO
08/07/19
UPGRADE
GSCO
Buy
Forterra upgraded two notches to Buy from Sell at Goldman Sachs
Goldman Sachs analyst Jerry Revich double-upgraded Forterra to Buy from Sell
08/07/19
GSCO
08/07/19
UPGRADE
Target $8
GSCO
Buy
Forterra upgraded to Buy from Sell at Goldman Sachs
Goldman Sachs analyst Jerry Revich double upgraded Forterra to Buy from Sell and raised his price target for the shares to $8.00 from $4.25. The company's entire senior management team has turned over and pricing is now accelerating despite declining input costs, Revich tells investors in a research note. He believes the latter is likely to drive multiple expansion if it is sustained in the coming quarters. Revich continues to prefer Aggregates producers for construction cycle exposure, and he views Forterra as a "high risk/high reward option for investors."

TODAY'S FREE FLY STORIES

REGN

Regeneron

$372.10

-1.41 (-0.38%)

05:26
12/13/19
12/13
05:26
12/13/19
05:26
Upgrade
Regeneron rating change  »

Regeneron upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

, EXEL

Exelixis

$17.68

0.05 (0.28%)

05:25
12/13/19
12/13
05:25
12/13/19
05:25
Hot Stocks
Genentech says Phase III IMspire150 study met primary endpoint of PFS »

Genentech, a member of…

RHHBY

Roche

$0.00

(0.00%)

EXEL

Exelixis

$17.68

0.05 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

HTHT

Huazhu Group

$34.86

0.92 (2.71%)

05:23
12/13/19
12/13
05:23
12/13/19
05:23
Upgrade
Huazhu Group rating change  »

Huazhu Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

05:22
12/13/19
12/13
05:22
12/13/19
05:22
Hot Stocks
Genentech says Phase III IMspire150 study met primary endpoint of PFS »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

SNAP

Snap

$14.45

0.22 (1.55%)

05:19
12/13/19
12/13
05:19
12/13/19
05:19
Upgrade
Snap upgraded to Outperform from Market Perform at JMP Securities »

JMP Securities analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$92.79

-2.2 (-2.32%)

05:16
12/13/19
12/13
05:16
12/13/19
05:16
Recommendations
Incyte analyst commentary  »

Incyte risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

PCG

PG&E

$11.75

-0.38 (-3.13%)

05:14
12/13/19
12/13
05:14
12/13/19
05:14
Hot Stocks
PG&E files amended plan of reorganization »

PG&E Corporation and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

05:12
12/13/19
12/13
05:12
12/13/19
05:12
Recommendations
Sarepta price target raised to $210 from $185 at Piper Jaffray »

Piper Jaffray analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOVE

Lovesac

$11.81

-2.68 (-18.50%)

05:07
12/13/19
12/13
05:07
12/13/19
05:07
Downgrade
Lovesac rating change  »

Lovesac downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 19

    Dec

TDOC

Teladoc

$77.06

-0.36 (-0.46%)

05:04
12/13/19
12/13
05:04
12/13/19
05:04
Initiation
Teladoc initiated  »

Teladoc initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTMI

TTM Technologies

$13.79

0.19 (1.40%)

05:01
12/13/19
12/13
05:01
12/13/19
05:01
Upgrade
TTM Technologies rating change  »

TTM Technologies upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FII

Federated Investors

$34.41

0.41 (1.21%)

05:01
12/13/19
12/13
05:01
12/13/19
05:01
Downgrade
Federated Investors rating change  »

Federated Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMK

AssetMark Financial

$27.31

0.42 (1.56%)

05:00
12/13/19
12/13
05:00
12/13/19
05:00
Upgrade
AssetMark Financial rating change  »

AssetMark Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCTR

Victory Capital

$21.68

0.235 (1.10%)

05:00
12/13/19
12/13
05:00
12/13/19
05:00
Downgrade
Victory Capital rating change  »

Victory Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EV

Eaton Vance

$47.08

0.395 (0.85%)

05:00
12/13/19
12/13
05:00
12/13/19
05:00
Upgrade
Eaton Vance rating change  »

Eaton Vance upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$60.47

-0.37 (-0.61%)

04:59
12/13/19
12/13
04:59
12/13/19
04:59
Initiation
Papa John's initiated  »

Papa John's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

NGLOY

Anglo American

$0.00

(0.00%)

04:57
12/13/19
12/13
04:57
12/13/19
04:57
Downgrade
Anglo American rating change  »

Anglo American assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Retail Sales less autos to be reported at 08:30 »

November Retail Sales…

COUP

Coupa Software

$136.91

-7.2 (-5.00%)

, CRWD

Crowdstrike

$47.25

-0.49 (-1.03%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
FBN to hold a bus tour »

17th Semi-Annual Silicon…

COUP

Coupa Software

$136.91

-7.2 (-5.00%)

CRWD

Crowdstrike

$47.25

-0.49 (-1.03%)

FEYE

FireEye

$16.33

0.095 (0.59%)

FSCT

ForeScout

$34.24

0.73 (2.18%)

FTNT

Fortinet

$104.45

0.29 (0.28%)

NOW

ServiceNow

$265.76

-1.665 (-0.62%)

NTAP

NetApp

$62.73

2.12 (3.50%)

PFPT

Proofpoint

$112.97

-0.03 (-0.03%)

PSTG

Pure Storage

$16.50

0.16 (0.98%)

QLYS

Qualys

$84.80

0.46 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 17

    Dec

  • 06

    Jan

  • 08

    Jan

  • 13

    Jan

  • 10

    Mar

  • 11

    Mar

  • 09

    Dec

ACB

Aurora Cannabis

$2.61

0.15 (6.10%)

, CRON

Cronos Group

$7.31

0.49 (7.18%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
MJBizDaily to hold a conference »

Marijuana Business…

ACB

Aurora Cannabis

$2.61

0.15 (6.10%)

CRON

Cronos Group

$7.31

0.49 (7.18%)

NFX

Newfield Exploration

$0.00

(0.00%)

CGC

Canopy Growth

$21.14

0.84 (4.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASML

ASML

$287.22

3.3 (1.16%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
ASML management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Breaking General news story  »

New York Federal Reserve…

04:55
12/13/19
12/13
04:55
12/13/19
04:55
General news
Breaking General news story  »

New York Federal Reserve…

UBX

Unity Biotechnology

$8.30

0.61 (7.93%)

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Recommendations
Unity Biotechnology analyst commentary  »

Unity Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

04:55
12/13/19
12/13
04:55
12/13/19
04:55
Conference/Events
BTIG biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.